DY
Therapeutic Areas
PainReform Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PRF-110 | Post-operative pain relief following bunionectomy | Phase 3 |
Leadership Team at PainReform
IH
Ilan Hadar
Chief Executive Officer and Director
DE
Dr. Eli Hazum
Chairman of the Board
DE
Dr. Ehud Geller
Executive Vice President, Research & Development
DY
Dr. Yossi Ben-David
Chief Financial Officer
DY
Dr. Yonatan Malach
Vice President, Clinical Development
DY
Dr. Yael Cohen
Director
DY
Dr. Yael Weiss
Director
DY
Dr. Yaron Daniely
Former Director